Santoso Andrew P, Vinogradskiy Yevgeniy, Robin Tyler P, Goodman Karyn A, Schefter Tracey E, Miften Moyed, Jones Bernard L
Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado.
Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Adv Radiat Oncol. 2023 Nov 23;9(3):101409. doi: 10.1016/j.adro.2023.101409. eCollection 2024 Mar.
Positional errors resulting from motion are a principal challenge across all disease sites in radiation therapy. This is particularly pertinent when treating lesions in the liver with stereotactic body radiation therapy (SBRT). To achieve dose escalation and margin reduction for liver SBRT, kV real-time imaging interventions may serve as a potential solution. In this study, we report results of a retrospective cohort of liver patients treated using real-time 2D kV-image guidance SBRT with emphasis on the impact of (1) clinical workflow, (2) treatment accuracy, and (3) tumor dose.
Data from 33 patients treated with 41 courses of liver SBRT were analyzed. During treatment, planar kV images orthogonal to the treatment beam were acquired to determine treatment interventions, namely treatment pauses (ie, adequacy of gating thresholds) or treatment shifts. Patients were shifted if internal markers were >3 mm, corresponding to the PTV margin used, from the expected reference condition. The frequency, duration, and nature of treatment interventions (ie, pause vs shift) were recorded, and the dosimetric impact associated with treatment shifts was estimated using a machine learning dosimetric model.
Of all fractions delivered, 39% required intervention, which took on average 1.9 ± 1.6 minutes and occurred more frequently in treatments lasting longer than 7 minutes. The median realignment shift was 5.7 mm in size, and the effect of these shifts on minimum tumor dose in simulated clinical scenarios ranged from 0% to 50% of prescription dose per fraction.
Real-time kV-based imaging interventions for liver SBRT minimally affect clinical workflow and dosimetrically benefit patients. This potential solution for addressing positional errors from motion addresses concerns about target accuracy and may enable safe dose escalation and margin reduction in the context of liver SBRT.
运动导致的位置误差是放射治疗中所有疾病部位面临的主要挑战。在使用立体定向体部放射治疗(SBRT)治疗肝脏病变时,这一问题尤为突出。为实现肝脏SBRT的剂量递增和 margins 缩小,千伏实时成像干预可能是一种潜在的解决方案。在本研究中,我们报告了一组使用二维千伏实时影像引导SBRT治疗的肝脏患者的回顾性队列研究结果,重点关注(1)临床工作流程、(2)治疗准确性和(3)肿瘤剂量的影响。
分析了33例接受41疗程肝脏SBRT治疗患者的数据。治疗期间,获取与治疗束正交的平面千伏图像,以确定治疗干预措施,即治疗暂停(即门控阈值是否合适)或治疗移位。如果内部标记相对于预期参考状态偏离>3 mm(对应于所使用的计划靶体积 margins),则对患者进行移位。记录治疗干预措施(即暂停与移位)的频率、持续时间和性质,并使用机器学习剂量模型估计与治疗移位相关的剂量学影响。
在所有照射野中,39% 需要干预,平均耗时1.9±1.6分钟,且在持续时间超过7分钟的治疗中更频繁发生。重新定位移位的中位数大小为5.7 mm,在模拟临床场景中,这些移位对最小肿瘤剂量的影响范围为每分次处方剂量的0%至50%。
用于肝脏SBRT的基于千伏的实时成像干预对临床工作流程的影响最小,并在剂量学上使患者受益。这种解决运动导致的位置误差的潜在解决方案解决了对靶区准确性的担忧,并可能在肝脏SBRT的背景下实现安全的剂量递增和 margins 缩小。